Overview

Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer

Status:
Completed
Trial end date:
2017-08-31
Target enrollment:
Participant gender:
Summary
To compare the kinetics and efficacy of two functionally different diagnostic agents, Lymphoseek (CD206 receptor targeted) and 99mTc-Sulfur Colloid (SC) (Sulfur Colloid non-specific mapping agent) in intraoperative lymphatic mapping (ILM) and Sentinel Lymph Node Biopsy (SLNB).
Phase:
Phase 4
Details
Lead Sponsor:
Kettering Health Network
Treatments:
Dextrans
Technetium Tc 99m Pentetate